What pulmonary infection is commonly associated with cystic fibrosis?

Prepare for the NBME Form 15 Test with our tailored quiz featuring flashcards and multiple-choice questions, each with hints and detailed explanations. Achieve success with our comprehensive study materials!

Multiple Choice

What pulmonary infection is commonly associated with cystic fibrosis?

Explanation:
Cystic fibrosis is a genetic disorder that primarily affects the lungs and digestive system, leading to the production of thick, viscous mucus. This mucus creates an environment conducive to bacterial growth and chronic lung infections. Pseudomonas aeruginosa is a common pathogen associated with cystic fibrosis patients. This organism is adept at thriving in the thick mucus and forms biofilms, making it particularly difficult to eradicate with standard antibiotic treatment. The chronic colonization of Pseudomonas aeruginosa leads to recurrent respiratory infections, lung damage, and ultimately contributes to the decline in lung function in individuals with cystic fibrosis. Given these factors, the association of Pseudomonas aeruginosa as a frequent infective agent in cystic fibrosis patients is well-established, making it the correct choice for the pulmonary infection commonly linked with this condition.

Cystic fibrosis is a genetic disorder that primarily affects the lungs and digestive system, leading to the production of thick, viscous mucus. This mucus creates an environment conducive to bacterial growth and chronic lung infections.

Pseudomonas aeruginosa is a common pathogen associated with cystic fibrosis patients. This organism is adept at thriving in the thick mucus and forms biofilms, making it particularly difficult to eradicate with standard antibiotic treatment. The chronic colonization of Pseudomonas aeruginosa leads to recurrent respiratory infections, lung damage, and ultimately contributes to the decline in lung function in individuals with cystic fibrosis.

Given these factors, the association of Pseudomonas aeruginosa as a frequent infective agent in cystic fibrosis patients is well-established, making it the correct choice for the pulmonary infection commonly linked with this condition.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy